Plasma from healthy young people treatment + Riluzole ( DrugBank: Riluzole )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 2 | 筋萎縮性側索硬化症 | 1 |
2. 筋萎縮性側索硬化症
臨床試験数 : 645 / 薬物数 : 589 - (DrugBank : 163) / 標的遺伝子数 : 150 - 標的パスウェイ数 : 225
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04454840 (ClinicalTrials.gov) | May 1, 2016 | 29/6/2020 | Treatment of Intravenous Infusion Plasma in Amyotrophic Lateral Sclerosis | A Clinical Study on Safety and Effectiveness of Intravenous Infusion Plasma From Healthy Young People to Treat Amyotrophic Lateral Sclerosis | Amyotrophic Lateral Sclerosis | Biological: Plasma from healthy young people treatment + Riluzole;Drug: Riluzole | Peking University Third Hospital | NULL | Completed | N/A | N/A | All | 20 | Early Phase 1 | China |